P1049: A PHASE 2 STUDY OF BEZUCLASTINIB (CGT9486), A NOVEL, HIGHLY SELECTIVE, POTENT KIT D816V INHIBITOR, IN ADULTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS (APEX): METHODS, BASELINE DATA, AND EARLY INSIGHTS

oleh: D. J. DeAngelo, V. Pullarkat, M. Piris-Villaespesa, T. I. George, J. L. Patel, C. Ustun, P. Bose, M. L. Heaney, A. Pilla, M. Massaro, B. Exter, H. A. Jolin, Z. Mikhak, T. Tashi